Sort
15,273 grants matching “antimicrobial resistance”
Pathogenesis of pneumococcal otitis media
$321,938Jian-Dong Li · Georgia State University · R01 · FY2016 · DC
Continued development of WHONET for surveillance of infections & drug resistance
$321,861John Stelling · Brigham And Women'S Hospital · R01 · FY2008 · RR
Bacillus Anthracis
$321,860Ordway Research Institute, Inc. · P01 · FY2005 · AI
Roles of Peptidases in Chronic Airway Inflammation
$321,845George H Caughey · University Of California, San Francisco · P01 · FY2014 · HL
Prevention of Biofilm Related Infections Using a Novel, Broad Spectrum Antimicrob
$321,829Roy Drake Bloebaum · University Of Utah · R01 · FY2011 · AR
Prevention of Biofilm Related Infections Using a Novel, Broad Spectrum Antimicrob
$321,829Roy Drake Bloebaum · University Of Utah · R01 · FY2012 · AR
Targeting Non-mammalian Isoprenoid Biosynthesis
$321,772Caren L. Freel Meyers · Johns Hopkins University · R01 · FY2016 · GM
Targeting Non-mammalian Isoprenoid Biosynthesis
$321,772Caren L. Freel Meyers · Johns Hopkins University · R01 · FY2017 · GM
Targeting Non-mammalian Isoprenoid Biosynthesis
$321,772Caren L. Freel Meyers · Johns Hopkins University · R01 · FY2018 · GM
Studies on the Pseudomonas aeruginosa cell-to-cell signal PQS
$321,750Everett C Pesci · East Carolina University · R01 · FY2008 · AI
Nasal carriage of S. aureus: host-pathogen interactions
$321,750Alexander M Cole · University Of Central Florida · R01 · FY2006 · AI
The Outer Surface of Vibrio cholerae
$321,719Michael Stephen Trent · University Of Texas At Austin · R01 · FY2012 · AI
Regulation of biofilm formation in clinical isolates of Staphylococcus aureus
$321,706Mark S Smeltzer · Univ Of Arkansas For Med Scis · R01 · FY2007 · AI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections
$321,674Huizhou Fan · Univ Of Med/Dent Nj-R W Johnson Med Sch · R33 · FY2010 · AI
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
$321,666Jingwei Xie · University Of Nebraska Medical Center · R01 · FY2018 · GM
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
$321,666Jingwei Xie · University Of Nebraska Medical Center · R01 · FY2020 · GM
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
$321,666Jingwei Xie · University Of Nebraska Medical Center · R01 · FY2019 · GM
Uterine microbiome: Functional significance in establishing the uterine program postpartum
$321,625Matthew C Lucy · University Of Missouri-Columbia · R01 · FY2020 · HD
Uterine microbiome: Functional significance in establishing the uterine program postpartum
$321,625Matthew C Lucy · University Of Missouri-Columbia · R01 · FY2019 · HD
Staphylococcal Adaptations to Platelet Microbicidal Protein
$321,581Arnold S Bayer · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2010 · AI
Pseudomonas aeruginosa lipid A
$321,486Robert K Ernst · University Of Maryland Baltimore · R01 · FY2008 · AI
Pseudomonas aeruginosa lipid A
$321,486Robert K Ernst · University Of Maryland Baltimore · R01 · FY2009 · AI
Aminoglycoside Resistance in Enterococci
$321,486Sergei Vakulenko · University Of Notre Dame · R01 · FY2008 · AI
Aminoglycoside Resistance in Enterococci
$321,486Sergei Vakulenko · University Of Notre Dame · R01 · FY2009 · AI
Ontogeny Of Oral Epithelial Antimicrobial Peptides
$321,454Aaron Weinberg · Case Western Reserve University · R01 · FY2010 · DE